Literature DB >> 15692258

How a damaged blood vessel wall contibutes to thrombosis and hypertenasion.

Andrew D Blann1.   

Abstract

In order to maintain an anticoagulant nature, the healthy endothelium secretes factors such as tissue plasminogen activator, ADPase, and expresses membrane thrombomodulin. However, when damaged, it releases increased amounts of pro-coagulants such as von Willebrand factor. Similarly, the healthy endothelium uses nitric oxide, prostacyclin and other molecules to help maintain normal blood pressure, and these molecules also inhibit platelet activity. But a dysfunctional endothelium fails to produce these vasodilators so that vasospasm and hypertension can result. Thus the (damaged/dysfunctional) endothelium can contribute to Virchow's triad by failing to maintain an anticoagulant surface and in failing to correctly regulate blood pressure, factors that are likely to promote thrombosis and hypertension.

Entities:  

Mesh:

Year:  2003        PMID: 15692258     DOI: 10.1159/000083843

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  17 in total

Review 1.  Nonclinical aspects of venous thrombosis in pregnancy.

Authors:  Evi Struble; Wafa Harrouk; Albert DeFelice; Belay Tesfamariam
Journal:  Birth Defects Res C Embryo Today       Date:  2015-09-25

Review 2.  Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.

Authors:  Kim A Eagle; Geoffrey S Ginsburg; Kiran Musunuru; William C Aird; Robert S Balaban; Susan K Bennett; Roger S Blumenthal; Shaun R Coughlin; Karina W Davidson; Edward D Frohlich; Philip Greenland; Gail P Jarvik; Peter Libby; Carl J Pepine; Jeremy N Ruskin; Arthur E Stillman; Jennifer E Van Eyk; H Eser Tolunay; Cheryl L McDonald; Sidney C Smith
Journal:  Circulation       Date:  2010-03-30       Impact factor: 29.690

Review 3.  Impact of drugs on venous thromboembolism risk in surgical patients.

Authors:  Alenka Premuš Marušič Kovačič; Martin Caprnda; Aleš Mrhar; Peter Kubatka; Igor Locatelli; Barbora Zolakova; Ludovit Gaspar; Robert Prosecky; Peter Kruzliak; Robert Staffa; Luis Rodrigo; Jozef Radonak; Danijel Petrovič
Journal:  Eur J Clin Pharmacol       Date:  2019-02-05       Impact factor: 2.953

Review 4.  The role of molecular imaging in diagnosis of deep vein thrombosis.

Authors:  Sina Houshmand; Ali Salavati; Søren Hess; Mudalsha Ravina; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

5.  Polypharmacotherapy and blood products as risk factors for venous thromboembolism in postsurgical patients: a case-control study.

Authors:  Alenka Premuš Marušič; Daniel Petrovič; Aleš Mrhar; Igor Locatelli
Journal:  Int J Clin Pharm       Date:  2017-03-09

Review 6.  Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease.

Authors:  Joseph Ramli; Pedro CalderonArtero; Robert C Block; Shaker A Mousa
Journal:  Cardiol J       Date:  2011       Impact factor: 2.737

Review 7.  The Impact of Pazopanib on the Cardiovascular System.

Authors:  Cody N Justice; Mohamed H Derbala; Tesla M Baich; Amber N Kempton; Aaron S Guo; Thai H Ho; Sakima A Smith
Journal:  J Cardiovasc Pharmacol Ther       Date:  2018-04-29       Impact factor: 2.457

8.  Autocrine VEGF signaling is required for vascular homeostasis.

Authors:  Sunyoung Lee; Tom T Chen; Chad L Barber; Maria C Jordan; Jared Murdock; Sharina Desai; Napoleone Ferrara; Andras Nagy; Kenneth P Roos; M Luisa Iruela-Arispe
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

9.  Direct Observation of Early-Stage High-Dose Radiotherapy-Induced Vascular Injury via Basement Membrane-Targeting Nanoparticles.

Authors:  Kin Man Au; Sayed Nabeel Hyder; Kyle Wagner; Caihong Shi; Young Seok Kim; Joseph M Caster; Xi Tian; Yuanzeng Min; Andrew Z Wang
Journal:  Small       Date:  2015-11-18       Impact factor: 13.281

Review 10.  Drug-induced thrombosis: an update.

Authors:  Yuval Ramot; Abraham Nyska; Galia Spectre
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.